Anthrax test, developed by army and CDC, receives FDA approval
5th Sep 2005, 14:07 GMT
A method for identifying Bacillus anthracis, the causative agent of anthrax, has been cleared for diagnostic use by the U.S. Food and Drug Administration. The test, called the Gamma Phage Assay, was modified by scientists at the U.S. Army Medical Research Institute of Infectious Diseases to improve its performance and reliability when used with clinical specimens. The original form of the assay was developed by the Centers for Disease Control and Prevention in the mid-1950s.
Latest news from EurekAlert! - Policy and Ethics:
- Bariatric surgery complication rates high in some hospitals, new HealthGrades ratings and study show
- A company's reputation is what gets fried when its books get cooked
- Sensor networks protect containers, navigate robots
- Queen's Surveillance Project benchmarks global attitudes about being watched
- Elderly, ill men get unneeded prostate cancer screenings
- Want fair and affordable health insurance for the uninsured? Ask the public to design it
- New book by University of Minnesota historian exposes Turkey's responsibility in Armenian genocide
- The Last Great Wilderness
- 'Moral clarity' espoused in debate over health-care reform
- RAND study says US should greatly expand efforts